ONYX PHARMACEUTICALS INC's ticker is and the CUSIP is 683399AB5. A total of 20 filers reported holding ONYX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2013 | $25,801,000 | – | 8,035,000 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TENOR CAPITAL MANAGEMENT Co., L.P. | 40,380,000 | $129,999,000 | 12.29% |
GLAZER CAPITAL, LLC | 6,785,000 | $21,895,000 | 6.50% |
WHITEBOX ADVISORS LLC | 23,848,000 | $76,525,000 | 4.04% |
ANGELO GORDON & CO., L.P. | 11,500,000 | $36,843,000 | 2.38% |
Kohlberg Kravis Roberts & Co. L.P. | 32,877,000 | $105,206,000 | 1.99% |
Polar Asset Management Partners Inc. | 7,500,000 | $24,061,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 8,035,000 | $25,801,000 | 0.53% |
D. E. Shaw & Co., Inc. | 35,580,000 | $114,163,000 | 0.18% |
AQR Capital Management | 11,885,000 | $38,136,000 | 0.13% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,104,000 | $6,741,000 | 0.07% |